Similar articles

• Aspirin, PIK3CA mutation, and colorectal-cancer survival.

  Sahin IH, Garrett C. Sahin IH, et al. N Engl J Med. 2013 Jan 17;368(3):289. doi: 10.1056/NEJMc1214189. N Engl J Med. 2013. PMID: 23323915 No abstract available.
• Aspirin, PIK3CA mutation, and colorectal-cancer survival.

  Viúdez A, Hernandez I, Vera R. Viúdez A, et al. N Engl J Med. 2013 Jan 17;368(3):289. doi: 10.1056/NEJMc1214189. N Engl J Med. 2013. PMID: 23323914 No abstract available.
• Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

  Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S. Liao X, et al. N Engl J Med. 2012 Oct 25;367(17):1596-606. doi: 10.1056/NEJMoa1207756. N Engl J Med. 2012. PMID: 23094721 Free PMC article.
• Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

  Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Ogino S, et al. Oncogene. 2014 Jun 5;33(23):2949-55. doi: 10.1038/onc.2013.244. Epub 2013 Jun 24. Oncogene. 2014. PMID: 23792451 Free PMC article. Review.
• PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.

  Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi A. Paleari L, et al. Clin Oncol (R Coll Radiol). 2016 May;28(5):317-26. doi: 10.1016/j.clon.2015.11.008. Epub 2015 Dec 17. Clin Oncol (R Coll Radiol). 2016. PMID: 26712086 Review.